Langali (Gloriosa superba) Linn. and its therapeutic importance in Ayurveda - a review
Keywords:Langali, Gloriosa superba, Ayurveda, upavisha
Langali, a drug of herbal origin, has been used by the Ayurvedic physicians, for the management of different disease conditions. The botanical source of the plant is Gloriosa superba Linn. of the family liliaceae. It is a climber with very attractive or glorious flowers hence the name as such. The drug langali, has been categorized as one of the nine upavishas (semipoisonous) of Ayurvedic pharmacopoeias. In this article an attempt has been made to collect the information related to langali from six samhitas, seven samgraha grantha, seven nighantu and five other texts. It is observed that the drug is used in 158 formulations, which are effective in more than 30 disease conditions among which aparapatana (removal of placenta), mudhagarbha (dead foetus), vrana (wound), agnimandya (loss of appetite), jvara (fever), grahani (Irritable bowel syndrome), kasa (cough), hikka (hiccough), kushtha (leprosy), shvitra (leucoderma), visarpa (erysipelas), arsha (piles) etc. Useful part of the plant is root with a dose of 125 - 250 mg and should be administered internally after passing through various shodhana procedures. It is used in various dosage forms such as svarasa, kvatha, lepa, varti, avaleha, taila, rasa, vati, kshara, modaka, ghruta, loha, rasakriya, churna, dhupa, nasya and udvartana.
How to Cite
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.